Blood Cell Membrane-Coated Nanomaterials as a Versatile Biomimetic Nanoplatform for Antitumor Applications

The application of nanomaterials in tumor therapy is increasingly widespread, offering more possibilities for enhanced tumor therapy. However, the unclear biological distribution and metabolism of nanomaterials may lead to immune rejection or inflammatory reactions, posing numerous challenges to the...

Full description

Saved in:

Bibliographic Details
Published in:	Nanomaterials (Basel, Switzerland) Vol. 14; no. 21; p. 1757
Main Authors:	Shen, Hanchun, Ouyang, Yongliang, Zhang, Liang, Li, Jing, Wang, Shige
Format:	Journal Article
Language:	English
Published:	Basel MDPI AG 31-10-2024 MDPI
Subjects:	Antigens Antitumor activity Bioavailability Biocompatibility Biomimetics Blood & organ donations Blood cells blood cells membrane Blood circulation Blood platelets Cancer Cancer therapies Care and treatment Cell membranes Cells Chemotherapy Cytotoxicity Drug delivery systems Gold Immune response Immune system Leukocytes Membranes Nanomaterials Nanoparticles Nanotechnology Neutrophils Peptides Polyethylene glycol Proteins Quantum dots Rejection Review Synergistic effect Therapy tumor therapy Tumors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The application of nanomaterials in tumor therapy is increasingly widespread, offering more possibilities for enhanced tumor therapy. However, the unclear biological distribution and metabolism of nanomaterials may lead to immune rejection or inflammatory reactions, posing numerous challenges to their clinical translation. The rich diversity and multifaceted functions of blood cells offer promising biological avenues for enhancing the application of nanoparticles in cancer therapy. Blood cell membranes, being made of naturally found components in the body, exhibit significant biocompatibility, which can reduce the body’s immune rejection response, extend the drug’s residence time in the bloodstream, and enhance its bioavailability. Integrating blood cell membranes with nanomaterials enhances tumor therapy by improving targeted delivery, prolonging circulation time, and evading immune responses. This review summarizes recent advancements in the application of blood cell membrane-coated nanomaterials for antitumor therapy, with a particular focus on their use in photodynamic and photothermal treatments. Additionally, it explores their potential for synergistic effects when combined with other therapeutic modalities.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ISSN:	2079-4991 2079-4991
DOI:	10.3390/nano14211757